Jasper Therapeutics Target Price

Analysts' average 12-month price target for Jasper Therapeutics is $3.

Get informed when a big investor buys or sells

+ Follow

Share Price

$0.67

Average Target Price

$3.00

350.8% upside

1 analysts in the last 4 months

High: $3 | Low: $3

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-05-15	RBC Capital	$3	350.8% upside
2025-01-09	RBC CapitalGregory Renza	$48	7112.6% upside
2024-12-05	BMO CapitalEtzer Darout	$63	9366.6% upside
2024-05-06	H.C. WainwrightEmily Bodnar	$65	9667.1% upside
2024-04-03	Evercore ISIGavin Clark-Gartner	$65	9667.1% upside
2023-02-07	Cantor Fitzgerald	$6	801.6% upside
2023-01-11	Credit Suisse	$3	350.8% upside

Jasper Therapeutics (JSPR) FAQ

Jasper Therapeutics's target price stands at $3. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

The Street's average target of $3 for JSPR implies 350.8% upside versus today's price ($0.67). Positive implied upside usually reflects optimism on growth or margins, while a large downside can signal valuation or fundamental concerns. Check recommendation mix and recent target changes for more context.

The history chart shows how Jasper Therapeutics's target price evolved across reporting periods, while the comparison chart places JSPR next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.